CARE Act of 2025
Summary
The CARE Act of 2025 (S.3145) requires CMS to test a Medicare payment model for ground ambulance dispatches that do not result in transport, creating a new revenue stream for ambulance providers and ancillary services. While only introduced and referred to committee, the bipartisan sponsorship and House companion bill provide credible legislative momentum. Evolent Health ($EVH) and Labcorp ($LH) are positioned as indirect beneficiaries through care coordination platforms and diagnostic lab services, respectively. The bill has no explicit funding authorization — it mandates a model test, not direct appropriations.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.The CARE Act creates a new Medicare payment model for non-transport ambulance dispatches, but is early-stage with a long legislative path ahead.
- 2.No direct funding authorization — the bill mandates CMS develop and test a payment model, which could take 2+ years post-enactment to produce actual revenue.
- 3.$EVH has rallied 62.72% in 30 days and may already price in some legislative optimism; $LH at -1.72% has not yet reacted, offering more asymmetric upside.
- 4.Bipartisan sponsorship (Collins-R + Welch-D) and a House companion bill increase structural passage probability but do not accelerate the timeline.
- 5.The 'under arrangement' provision allows third-party contractors (diagnostic labs, care coordination platforms) to directly participate in the new payment model.
Market Implications
The immediate market impact is minimal — the bill is in early legislative stage with no defined funding or timeline. However, the structural shift toward paying for non-transport emergency response creates a long-term revenue expansion for technology platforms that enable care coordination and remote diagnostics. $EVH at $3.72 (near 52-week low) has already begun to discount this opportunity, while $LH at $262.24 has not. Investors should monitor committee activity: a markup or hearing would be a concrete catalyst for these names. The risk is legislative failure or lengthy delay, which would remove the catalyst without near-term earnings support.
Full Analysis
-
WHAT HAPPENED: The CARE Act (Comprehensive Alternative Response for Emergencies Act) was introduced in the Senate on November 6, 2025 by Sen. Collins (R-ME) with 9 cosponsors, and referred to the Committee on Finance. A companion bill (HR2538) was introduced in the House and referred to Energy and Commerce and Ways and Means. The bill is in early legislative stage — it requires committee markup, floor votes in both chambers, and presidential signature. The current bill status is 'Referred to committee — early stage.' The concept has bipartisan sponsorship (Collins is a senior Republican; the lead Democratic cosponsor is Sen. Welch of Vermont), but the path to enactment is long.
-
THE MONEY TRAIL: The CARE Act does NOT authorize or appropriate any specific dollar amount. It mandates that the CMS Innovation Center 'shall include' this model in its portfolio of mandatory model tests by a date 'not later than 2 years after enactment.' The financial impact is indirect: it creates Medicare billing codes and payment rates for non-transport ambulance services. Actual federal spending will depend on CMS rulemaking to set those rates, provider uptake, and utilization volumes. The bill is an authorization for a payment model — real money flows only after CMS implements the model, which could take 2-5 years. This is a structural market expansion, not a near-term revenue event.
-
STRUCTURAL WINNERS AND LOSERS: Primary beneficiaries are ground ambulance service providers (not publicly traded pure-plays — most are municipal, private equity, or hospital-owned), diagnostic laboratories ($LH, $DGX), and care coordination technology platforms ($EVH). The bill allows services to be furnished 'under arrangement' with ambulance providers, creating a legal pathway for third-party contractors. Telehealth and remote diagnostic providers may also benefit if the model permits online medical direction and remote testing. Companies solely dependent on emergency transport volume face no downside since non-transport calls currently generate zero revenue — the model adds a new billing option without reducing transport payments.
-
REAL MARKET DATA ANALYSIS: $EVH at $3.72 has surged 62.72% over 30 days and 18.53% over 7 days, trading near the very bottom of its 52-week range ($2.10-$12.07). This rally is likely driven by multiple factors including broader sector rotation toward value-based care; the CARE Act provides a specific legislative catalyst that could extend this momentum if the bill advances. $LH at $262.24 is down 1.72% over 30 days and 0.6% over 7 days, trading near the middle of its 52-week range ($235.81-$293.72). The minimal recent movement suggests the market has not yet priced in the bill's potential impact. LH's large diversified business (diagnostics, drug development) means the CARE Act impact would be small relative to total revenue, explaining the muted price reaction.
-
TIMELINE: The earliest realistic timeline: Committee markup in summer 2026, Senate floor vote in fall 2026, House passage in early 2027, signature mid-2027. CMS would then have 2 years from enactment to implement the model, meaning actual payment changes would not occur until 2029 at the earliest. This is a long-duration catalyst — not a near-term earnings driver.
Intelligence Surface
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
Some confirming evidence found across public data sources
What the bill does
Mandatory CMS Innovation Center model test requiring Medicare payment for ground ambulance dispatch without transport, creating a new billing code and revenue stream for care coordination and alternative response services.
Who must act
Centers for Medicare & Medicaid Services (CMS) Innovation Center, must implement payment model within 2 years of enactment for services furnished by ground ambulance providers or entities under arrangement with such providers.
What happens
Creates a new Medicare Part B payment pathway for non-transport emergency response, enabling ambulance providers and their contracted partners to bill for triage, telehealth, and referral services that previously went uncompensated.
Stock impact
Evolent Health ($EVH) provides value-based care platforms and population health management services that could be contracted by ambulance providers to coordinate alternative response programs. The new payment model directly expands the addressable market for care coordination technology in emergency medical services. EVH's recent 7-day +18.53% and 30-day +62.72% rallies likely reflect broader sector momentum; the CARE Act provides additional structural support for revenue growth in this niche.
What the bill does
Medicare payment for non-transport ambulance services may include diagnostic services furnished under arrangement with the ambulance provider, allowing labs to bill for tests performed at scene or via telemedicine during alternative response.
Who must act
Ground ambulance providers and suppliers, who may contract with diagnostic laboratories to furnish testing services during non-transport emergency responses.
What happens
Expands the settings in which Medicare reimburses diagnostic lab services, potentially increasing utilization of point-of-care and remote lab testing in emergency scenarios where patients are treated on-site rather than transported.
Stock impact
Labcorp ($LH) is a national diagnostic laboratory network capable of providing point-of-care testing services and supporting remote lab interpretation for ambulance-based alternative response programs. The bill creates an incremental revenue opportunity for diagnostic services in a new care setting. LH's recent 7-day -0.6% and 30-day -1.72% decline suggest broader headwinds; this legislation provides a targeted upside catalyst.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
SUPPORT for Patients and Communities Reauthorization Act of 2025
CHOICE for Veterans Act of 2025
THE LEWIN GROUP, INC.: $11.3M Department of Health and Human Services Contract
ASAP Act
Access to Breast Cancer Diagnosis Act of 2025
Supporting Healthy Moms and Babies Act
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Reducing Hereditary Cancer Act
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Ushering in the Next Frontier of Quantum Innovation
This executive order updates the National Quantum Strategy and establishes a national effort (QC-ADDS) to develop a quantum computer for scientific discovery, with deployment at a Department of Energy facility. It directs multiple agencies to prioritize quantum sensing, networking, and supply chain initiatives, and mandates plans for commercial readiness and national security applications.
Securing the Nation Against Advanced Cryptographic Attacks
This executive order mandates a nationwide transition of federal information systems and critical infrastructure to post-quantum cryptography (PQC) by specific deadlines (2030 for key establishment, 2031 for digital signatures), directs NIST to lead technical guidance and a pilot project, requires agencies to appoint PQC migration leads, and orders the Federal Acquisition Regulatory Council to propose rules requiring contractors to comply with NIST PQC standards by 2030.
National Security Presidential Memorandum/NSPM-12
This memorandum rescinds previous national security directives and re-establishes the Committee on National Security Systems (CNSS) to enforce baseline cybersecurity standards across all National Security Systems (NSS) operated by the Department of War, Intelligence Community, and Federal Civilian Executive Branch agencies. It creates binding directives and complementary standards that must meet or exceed NIST guidelines, empowers the NSA Director as the National Manager to issue emergency directives and cryptography requirements, and holds agency heads accountable through government-wide oversight.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →